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A SIGNIFICANT number of nonislet cells still remains in cell suspensions from human islet cell prepara-
tions obtained by our previously described method. I •2 
Nonislet components such as acinar cells or immunogenic 
hematolymphoid cells could have adverse effects on initial 
graft taking as well as long-term graft survival through 
mechanisms of enzymatic injury and initiation of rejec-
tion.J In this study, we have examined in detail the cellular 
I 
composition of islet cell suspensions using paraffin-embed-
ded cell pellets of the isolates immediately after purifica-
tion and after 1 week in culture medium. 
MATERIALS AND METHODS 
Human Islets obtained from SIX different multiorgan donors were 
separated and purified by the automated method and Euro-
Collins-Ficoll gradient separauon using the COBE 2991 cell pro-
cessor.1.1 A pOnlon of the suspension was fixed in buffered 
formaldehyde. and cell pellets were obtained by centrifugation at 
800 f( for 3 minutes. Additional pellets were prepared after the 
remaining suspensions were maintained in CMRL-l066 culture 
medium at 30"C in 5% CO2 for I week. All formalin-fixed pel-
lets were paraffin embedded. secuoned. and stained with the avi-
din-biotin-complex (ABC) immunoperoxidase method. as de-
scribed by Hsu.· A panel of antibodies was used with antibodies 
directed against insulin. glucagon. chromogranin. actin (all Bio-
genex. San Ramon. CAl, AE-I. AE-3 (Boehringer Mannheim. 
Indianapolis. IN). vimentin (Sigma. St Louis. Mo). factor VIIIR-
Ag. Sioo. LCNCD45. MAC-387.lysozyme. UCHL-1. L261CD20 
(all DAKO. Santa Barbara. CaiiO. LN3/HLA-DR (Biotest Diag-
nosucs. Denville. NJ). and Leu-221CD43 (Becton-Dickinson. 
Mountam View. CaiiO. Small fractions from two preparations 
were fixed in 2% glutaraldehyde. postfixed in 1% osmium tetrox-
ide. embedded in Epon-Araldite resin. stained with 4% uranyl 
acetate followed by lead citrate. and examined with a Phillips EM 
300 transmission electron microscope. 
RESULTS AND DISCUSSION 
Immediately after separation. the isolates contained 30% 
to 80% islet cells; however, all other cell types found in 
normal pancreas were also present. This included 
HLA-DR and SI00 positive dendritic cells. which are 
known as potent stimulators of immune reactions. includ-
ing rejection. S The difference in purity of the various 
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preparations was mainly due to a different content of islet 
and acinar cells; whereas ductal. soft tissue. and hema-
tolymphoid cells comprised approximately 10% to 20% in 
all preparations. One week of culture had different effects 
on moderately and highly purified preparations: In less 
purified isolates (30% to 40% islets). the islet cell content 
dropped to as low as 5%. In addition. remaining islets cells 
weakly expressed HLA-DR. Remaining cells were almost 
exclusively acinar cells; however. scattered endothelial 
cells and a few lymphoid aggregates as well as very rare 
HLA-DR positive macrophages could still be detected. In 
contrast. highly purified isolates (70% to 80% islets I mainly 
showed decreased insulin content without significant loss 
of islet cells or new HLA-DR expression. Epithelial, soft 
tissue. and hematolymphoid elements decreased only min-
imally. It appears that reduction of immunogenic cells in 
islet cell suspensions cannot be achieved solely by primar-
ily mechanical purification procedures but requires addi-
tional measures. Short-term culture only reduces but does 
not eliminate immunogenic cells and is deleterious to islet 
cells if the initial content of acinar cells is high. 
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